(Q84511029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Longitudinal observations of serum heparin cofactor II-thrombin complex in treated Mucopolysaccharidosis I and II patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

main subject

mucopolysaccharidosis I

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

John J. Mitchell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Harmony Hemmelgarn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Karen Colobong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anita Thomas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sylvia Stockler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Robin Casey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Alicia Chan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Paul Fernoff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

6 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

355-362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732093%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10545-011-9369-6

6 February 2020

exact match

0 references

cites work

Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.

1 reference

12 December 2020

Therapeutic goals in Gaucher disease

1 reference

12 December 2020

Individualization of long-term enzyme replacement therapy for Gaucher disease

1 reference

12 December 2020

Mucopolysaccharidoses screening: dimethylmethylene blue versus alcian blue.

1 reference

12 December 2020

Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice

1 reference

12 December 2020

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

12 December 2020

A reappraisal of Gaucher disease-diagnosis and disease management algorithms.

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

12 December 2020

Heparin cofactor II–thrombin complex: A biomarker of MPS disease

1 reference

12 December 2020

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)

1 reference

12 December 2020

Heparin cofactor II–thrombin complex in MPS I: A biomarker of MPS disease

1 reference

12 December 2020

Transplant outcomes in mucopolysaccharidoses

1 reference

12 December 2020

A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I

1 reference

12 December 2020

Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases

1 reference

12 December 2020

Mechanisms of glycosaminoglycan activation of the serpins in hemostasis

1 reference

12 December 2020

The mucopolysaccharidoses: a success of molecular medicine.

1 reference

12 December 2020

Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome

1 reference

12 December 2020

Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans

1 reference

12 December 2020